[Federal Register Volume 65, Number 100 (Tuesday, May 23, 2000)]
[Notices]
[Pages 33354-33355]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-12844]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 30, 2000, Radian 
International LLC, 14050 Summit Drive #121, P.O. Box 201088, Austin, 
Texas 78720-1088, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                     Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).............................  I
Methcathinone (1237).........................  I
N-Ethylamphetamine (1475)....................  I
N-N-Dimethylamphetamine (1480)...............  I
Aminorex (1585)..............................  I
4-Methylaminorex (cis isomer) (1590).........  I
Methaqualone (2565)..........................  I
Alpha-Ethyltryptamine (7249).................  I
Lysergic acid diethylamide (7315)............  I
Tetrahydrocannabinols (7370).................  I
Mescaline (7381).............................  I
3,4,5-Trimethoxyamphetamine (7390)...........  I
4-Bromo-2,5-dimethoxyamphetamine (7391)......  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)...  I
4-Methyl-2,5-dimethoxyamphetamine (7395).....  I
2,5-Dimethoxyamphetamine (7396)..............  I
2,5-Dimethoxy-4-ethylamphetamine (7399)......  I
3,4-Methylenedioxyamphetamine (7400).........  I
5-Methoxy-3,4-methylenedioxyamphetamine        I
 (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine        I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404).  I
3,4-Methylenedioxymethamphetamine (7405).....  I
4-Methoxyamphetamine (7411)..................  I
Bufotenine (7433)............................  I
Diethyltryptamine (7434).....................  I
Dimethyltryptamine (7435)....................  I
Psilocybin (7437)............................  I
Psilocyn (7438)..............................  I
Acetyldihydrocodeine (9051)..................  I
Benzylmorphine (9052)........................  I
Codeine-N-oxide (9053).......................  I
Dihydromorphine (9145).......................  I
Heroin (9200)................................  I
Morphine-N-oxide (9307)......................  I
Normorphine (9313)...........................  I
Pholcodine (9314)............................  I
Acetylmethadol (9601)........................  I
Allyprodine (9602)...........................  I
Alphacetylmethadol except Levo-                I
 Alphacetylmethadol (9603).
Alphameprodine (9604)........................  I
Alphamethadol (9605).........................  I
Betacetylmethadol (9607).....................  I
Betameprodine (9608).........................  I
Betamethadol (9609)..........................  I
Betaprodine (9611)...........................  I
Hydromorphinol (9627)........................  I
Noracymethadol (9633)........................  I
Norlevorphanol (9634)........................  I
Normethadone (9635)..........................  I
Trimeperidine (9646).........................  I
Para-Fluorofentanyl (9812)...................  I
3-Methylfentanyl (9813)......................  I
Alpha-methylfentanyl (9814)..................  I
Acetyl-alpha-methylfentanyl (9815)...........  I
Beta-hydroxyfentanyl (9830)..................  I
Beta-hydroxy-3-methyfentanyl (9831)..........  I
Alpha-Methylthiofentanyl (9832)..............  I
3-Methylthiofentanyl (9833)..................  I
Thiofentanyl (9835)..........................  I
Amphetamine (1100)...........................  II
Methamphetamine (1105).......................  II
Phenmetrazine (1631).........................  II
Methylphenidate (1724).......................  II
Amobarbital (2125)...........................  II
Pentobarbital (2270).........................  II
Secobarbital (2315)..........................  II

[[Page 33355]]

 
Glutethimide (2550)..........................  II
Nabilone (7379)..............................  II
1-Phenylcyclohexylamine (7460)...............  II
Phencyclidine (7471).........................  II
1-Piperid-inocyclohexanecarbonitrile (8603)..  II
Alphaprodine (9010)..........................  II
Cocaine (9041)...............................  II
Codeine (9050)...............................  II
Dihydrocodeine (9120)........................  II
Oxycodone (9143).............................  II
Hydromorphone (9150).........................  II
Diphenoxylate (9170).........................  II
Benzoylecgonine (9180).......................  II
Ethylmorphine (9190).........................  II
Hydrocodone (9193)...........................  II
Levomethorphan (9210)........................  II
Levorphanol (9220)...........................  II
Isomethadone (9226)..........................  II
Meperidine (9230)............................  II
Methadone (9250).............................  II
Methadone-intermediate (9254)................  II
Morphine (9300)..............................  II
Levo-alphacetylmethadol (9648)...............  II
Oxymorphone (9652)...........................  II
Alfentanil (9737)............................  II
Sufentanil (9740)............................  II
Fentanyl (9801)..............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to make deuterated and nondeuterated drug 
reference standards which will be distributed to analytical and 
forensic laboratories for drug testing programs.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than July 24, 2000.

    Dated: May 11, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-12844 Filed 5-22-00; 8:45 am]
BILLING CODE 4410-09-M